The protective effect of montelukast sodium on carbon tetrachloride induced hepatopathy in rat

Prostaglandins and Other Lipid Mediators

Volumn 88, Issue 3-4, 2009, Pages 82-88

  Cuciureanu, Magdalena ^a   Cǎruntu, Irina Draga ^a   Pǎduraru, Ofelia ^a   Stoica, Bogdan ^a   Jerca, Luminita ^a   Crauciuc, Eduard ^a   Nechifor, Mihai ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

CCl4; Cysteinyl leukotrienes; Hepatoprotector; Liver; Montelukast

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; CARBON TETRACHLORIDE; CATALASE; GLUTATHIONE; MALONALDEHYDE; MONTELUKAST; SUPEROXIDE DISMUTASE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; FATTY LIVER; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER DISEASE; LIVER HISTOLOGY; LIVER HOMOGENATE; LIVER PROTECTION; MALE; NONHUMAN; RAT; THERAPY EFFECT; TISSUE SECTION; TREATMENT OUTCOME; TREATMENT RESPONSE; WISTAR RAT;

ACETATES; ALANINE TRANSAMINASE; ANIMALS; BILIRUBIN; CARBON TETRACHLORIDE; CATALASE; LIVER; LIVER DISEASES; MALE; MALONDIALDEHYDE; QUINOLINES; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 63149085579     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2008.10.004     Document Type: Article

References (46)

1. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 5548 (2001) 1871-1875
2. Brink C., Dahlén S.E., Drazen J., Evans J.F., Hay D.W., and Nicosia S. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors. Pharmacol Rev 55 1 (2003) 195-227
3. Sjöström M., Jakobsson P.J., Heimburger M., Palmblad J., and Haeggström J.Z. Human umbilical vein endothelial cells generate leukotriene C4 via microsomal glutathione S-transferase type 2 and express the CysLT(1) receptor. Eur J Biochem 268 9 (2001) 2578-2586
4. Di Gennaro A., Carnini C., Buccellati C., Ballerio R., Zarini S., and Fumagalli F. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes. FASEB J 18 7 (2004) 842-844
5. Titos E., Clària J., Planagumà A., López-Parra M., Villamor N., and Párrizas M. Inhibition of 5-lipoxygenase induces cell growth arrest and apoptosis in rat kupffer cells: implications for liver fibrosis. FASEB J 17 12 (2003) 1745-1747
6. Fukai F., Suzuki Y., Nishizawa Y., and Katayama T. Transcellular biosynthesis of cysteinyl leukotrienes by kupffer cell-hepatocyte cooperation in rat liver. Cell Biol Int 20 6 (1996) 423-428
7. Wettstein M., Gerok W., and Häussinger D. Characteristics of sinusoidal uptake and biliary excretion of cysteinyl leukotrienes in perfused rat liver. Eur J Biochem 191 1 (1990) 251-255
8. Meng X.J., Carruth M.W., and Weinman S.A. Leukotriene D4 activates a chloride conductance in hepatocytes from lipopolysaccharide-treated rats. J Clin Invest 99 12 (1997) 2915-2922
9. Uemura M., Lehmann W.D., Schneider W., Seitz H.K., Benner A., and Keppler-Hafkemeyer A. Enhanced urinary excretion of cysteinyl leukotrienes in patients with acute alcohol intoxication. Gastroenterology 118 6 (2000) 1140-1148
10. Richter L., Hesselbarth N., Eitner K., Schubert K., Bosseckert H., and Krell H. Increased biliary secretion of cysteinyl-leukotrienes in human bile duct obstruction. J Hepatol 25 5 (1996) 725-732
11. Kasirga E., Coker I., Aydoǧdu S., Yaǧci R.V., Taneli B., and Gousseinov A. Blood levels of leukotrienes (LTC4, D4, E4, B4) and synthesis of leukotriene B4 by peripheral leukocytes in children with acute A and B hepatitis. Turk J Pediatr 41 4 (1999) 457-465
12. Capella G.L. Anti-leukotriene drugs in the prevention and treatment of hepatorenal syndrome. Prostaglandins Leukot Essent Fatty Acids 68 4 (2003) 263-265
13. Huber M., Kästner S., Schölmerich J., Gerok W., and Keppler D. Analysis of cysteinyl leukotrienes in human urine: enhanced excretion in patients with liver cirrhosis and hepatorenal syndrome. Eur J Clin Invest 19 1 (1989) 53-60
14. Nagai H., Shimazawa T., Yakuo I., Aoki M., Koda A., and Kasahara M. Role of peptide-leukotrienes in liver injury in mice. Inflammation 13 6 (1989) 673-680
15. Satoh S., Uetake S., Ohata M., Nakajima H., and Yamauchi M. Effect of type of dietary fat and ethanol on hepatic leukotriene level in experimental alcoholic liver disease. Nihon Arukoru Yakubutsu Igakkai Zasshi 38 4 (2003) 350-363
16. Kawada N., Mizoguchi Y., Sakagami Y., Kobayashi K., Yamamoto S., and Morisawa S. Changes in leukotrienes and prostaglandins in the liver tissue of rats in the experimental massive hepatic cell necrosis model. Prostaglandins Leukot Essent Fatty Acids 40 2 (1990) 149-155
17. Takamatsu Y., Shimada K., Chijiiwa K., Kuroki S., Yamaguchi K., and Tanaka M. Role of leukotrienes on hepatic ischemia/reperfusion injury in rats. J Surg Res 119 1 (2004) 14-20
18. Graupera M., García-Pagán J.C., Titos E., Claria J., Massaguer A., and Bosch J. 5-Lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: a possible role of cysteinyl-leukotrienes. Gastroenterology 122 2 (2002) 387-393
19. Gonzàlez R., Ancheta O., Màrquez M., and Rodriguez S. Hepatoprotective effects of diethylcarbamazine in acute liver damage induced by carbon tetrachloride in rats. Zhongguo Yao Li Xue Bao 15 6 (1994) 495-497
20. Leonardi S., Marchese G., Marseglia G.L., and La Rosa M. Montelukast in allergic diseases beyond asthma. Allergy Asthma Proc 28 3 (2007) 287-291
21. Buege J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 52 (1978) 302-310
22. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 193 1 (1951) 265-275
23. Beers R.F., and Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195 1 (1952) 133-140
24. Beutler E. A manual of biochemical methods. Glutathione in red cell metabolism (1975), Grune and Stratton Inc, New York p. 112-4
25. Whitehead T.P., Thorpe G.H., and Maxwell S.R. Enhanced chemiluminiscence assay for antioxidant capacity in biological fluids. Anal Chim Acta 266 (1992) 265-277
26. Russell McLauchlan W., Sanderson J., Quinlan M., and Williamson G. Measurement of the total antioxidant activity of human aqueous humor. Clin Chem 44 (1998) 888-889
27. Minami M., and Yoshikawa H. A simplified assay method of superoxide dismutase activity for clinical use. Clin Chim Acta 92 (1979) 337-434
28. Cotran S.R., Kumar V., and Robbins S.L. Cellular pathology. In: Cotran S.R., Kumar V., and Robbins S.L. (Eds). Robbins's pathological basis of disease (1999), WB Saunders, Philadelphia 1-29
29. Clària J., and Jiménez W. Renal dysfunction and ascites in carbon tetrachloride-induced cirrhosis in rats. In: Arroyo V., Ginès P., Rodés J., and Schrier R.W. (Eds). Ascites and renal dysfunction in liver disease (1999), Blackwell Science, Malden, MA 379-396
30. 4. Inflamm Res 49 12 (2000) 700-707
31. Schröder O., Sjöström M., Qiu H., Jakobsson P.J., and Haeggström J.Z. Microsomal glutathione S-transferases: selective up-regulation of leukotriene C4 synthase during lipopolysaccharide-induced pyresis. Cell Mol Life Sci 62 1 (2005) 87-94
32. Titos E., Clària J., Planagumà A., López-Parra M., González-Périz A., and Gaya J. Inhibition of 5-lipoxygenase-activating protein abrogates experimental liver injury: role of kupffer cells. J Leukoc Biol 78 4 (2005) 871-878
33. Horrillo R., Planagumà A., González-Périz A., Ferré N., Titos E., and Miquel R. Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor. J Pharmacol Exp Ther 323 3 (2007) 778-786
34. Yang Y.Y., Lin H.C., Huang Y.T., Lee T.Y., Hou M.C., and Wang Y.W. Roles of anandamide in the hepatic microcirculation in cirrhotic rats. Am J Physiol Gastrointest Liver Physiol 290 2 (2006) 328-334
35. Kawada N., Mizoguchi Y., Kobayashi K., Yamamoto S., and Morisawa S. Arachidonic acid metabolites in carbon tetrachloride-induced liver injury. Gastroenterol Jpn 25 3 (1990) 363-368
36. Makogon N.V., Korneitchuk A.N., Lushnikova I.V., and Alexeyeva I.N. Effects of exogenous leukotrienes B4 and C4 on the viability of cultured rat hepatocytes. Acta Physiol Pharmacol Bulg 25 3-4 (2000) 87-91
37. Cui S., Shibamoto T., Takano H., Zhang W., and Kurata Y. Leukotrienes and cyclooxygenase products mediate anaphylactic venoconstriction in ovalbumin sensitized rat livers. Eur J Pharmacol 576 1-3 (2007) 99-106
38. Nieves D., and Moreno J.J. Role of 5-lipoxygenase pathway in the regulation of RAW 264.7 macrophage proliferation. Biochem Pharmacol 72 8 (2006) 1022-1030
39. Wikström K., Juhas M., and Sjölander A. The anti-apoptotic effect of leukotriene D4 involves the prevention of caspase 8 activation and Bid cleavage. Biochem J 371 (2003) 115-124
40. Romano M., and Claria J. Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB J 17 14 (2003) 1986-1995
41. 4-induced chronic liver injury in mice. Prostaglandins Leukot Essent Fatty Acids 40 1 (1990) 67-71
42. Pérez-Alvarez V., Bobadilla-Lugo R.A., Muriel P., Favari L., and Villanueva-López C. Effects of leukotriene synthesis inhibition on acute liver damage induced by carbon tetrachloride. Pharmacology 47 5 (1993) 330-336
43. Sener G., Sehirli O., Cetinel S., Ercan F., Yüksel M., Gedik N., and Yeǧen B.C. Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast. Prostaglandins Leukot Essent Fatty Acids 73 6 (2005) 453-462
44. Tomari S., Matsuse H., Machida I., Kondo Y., Kawano T., and Obase Y. Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen-specific tumour necrosis factor alpha production and nuclear factor kappa B nuclear translocation in peripheral blood monocytes from atopic asthmatics. Clin Exp Allergy 33 6 (2003) 795-801
45. Orfila C., Lepert J.C., Alric L., Carrera G., Béraud M., and Pipy B. Immunohistochemical distribution of activated nuclear factor kappaB and peroxisome proliferator-activated receptors in carbon tetrachloride-induced chronic liver injury in rats. Histochem Cell Biol 123 6 (2005) 585-593
46. Kawano T., Matsuse H., Kondo Y., Machida I., Saeki S., and Tomari S. Cysteinyl leukotrienes induce nuclear factor kappa b activation and RANTES production in a murine model of asthma. J Allergy Clin Immunol 112 2 (2003) 369-374